Investment adviser · CRD 342873

BANYAN BIO

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

BANYAN BIOINNOVATIONS CAPITAL FUND I LP

BOSTON, MA, United States · Form ADV filed Sep 9, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

1 Private fund

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

BANYAN BIOINNOVATIONS CAPITAL FUND I LPVenture Capital Fund · Last reported Sep 9, 2026$100MGross asset value

Form D fundraising filings

Banyan BioInnovations Capital Fund I LP

Auditor BERRY DUNN, MCNEIL & PARKER PORTLAND, Maine, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

BERRY DUNN, MCNEIL & PARKER
PCAOB 136

Fund details & source
Fund ID
805-8067040869
Reported beneficial owners
1
Minimum commitment
$10M
Form D file number
021-585997

Form ADV 2116515 · Sep 9, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Sep 9, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

420 BOYLSTON ST, 6TH FLOOR
BOSTON, MA, 02116, United States

CRD 342873

Filing source

Form ADV 2116515 · Sep 9, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.